北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (5): 806-811. doi: 10.3969/j.issn.1671-167X.2016.05.010

• 论著 • 上一篇    下一篇

T3N0M0期肾细胞癌患者预后相关因素分析:单中心182例患者回顾性研究

彭鼎*,李学松*,张崔建△,杨恺惟,唐琦,张雷,余霄腾,何志嵩,周利群△   

  1. (北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系肿瘤诊治中心,北京100034)
  • 出版日期:2016-10-18 发布日期:2016-10-18
  • 通讯作者: 张崔建,周利群 E-mail:surgeon_zhang@126.com, zhouliqunmail@sina.com

Prognostic factors of patients with T3N0M0 renal cell carcinoma: a single-center retrospective study of 182 patients

PENG Ding*, LI Xue-song*, ZHANG Cui-jian△, YANG Kai-wei, TANG Qi, ZHANG Lei, YU Xiao-teng, HE Zhi-song, ZHOU Li-qun△   

  1. (Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center; Beijing 100034, China)
  • Online:2016-10-18 Published:2016-10-18
  • Contact: ZHANG Cui-jian,ZHOU Li-qun E-mail:surgeon_zhang@126.com, zhouliqunmail@sina.com

摘要:

目的:研究影响T3N0M0期肾细胞癌患者肿瘤学预后的临床及实验室检查因素。方法:回顾性分析2007年至2012年于北京大学第一医院行手术治疗的T3N0M0肾细胞癌患者的临床资料、实验室检查结果及随访数据。应用Kaplan-Meier法计算生存率,Log-rank方法进行单因素分析,对单因素分析中显著相关的变量采用Cox模型进行多因素生存分析。结果:共182例T3N0M0肾细胞癌患者纳入研究,其中男性患者126例(69.23%),女性患者56例(30.77%)。患者平均年龄为(56.75±12.45)岁,中位随访时间48个月(3~99个月),末次随访时共有50例(27.47%)患者死亡,59例患者(32.42%)复发。患者的5年肿瘤特异性生存率为68.30% (95% CI: 60.16%~75.84%),5年无复发生存率为60.70%(95% CI: 53.16%~68.84%)。多因素分析发现,糖尿病(HR=2.434, 95% CI:1.243~4.769, P=0.010)、术前低白蛋白血症(HR=2.188, 95% CI:1.074~1.074, P=0.031)及贫血(HR=3.320, 95% CI:1.839~5.991, P<0.001)是T3N0M0肾细胞癌患者术后肿瘤特异生存的独立危险因素,更高的Fuhrman分级(HR=2.552, 95% CI:1.433~4.545, P=0.001)、术前贫血(HR=2.535, 95% CI:1.497~4.293, P=0.001)是T3N0M0肾细胞癌患者术后复发的独立危险因素。结论:糖尿病、术前低白蛋白血症、贫血是T3N0M0肾细胞癌患者术后生存的独立危险因素;高Fuhrman分级、贫血是T3N0M0肾细胞癌患者术后复发的独立危险因素。

关键词: 肾肿瘤, 癌, 肾细胞, 治疗结果, 肾切除术

Abstract:

Objective: To evaluate the impacts of clinical, pathological, and laboratory factors on oncological outcomes of patients with T3N0M0 renal cell carcinoma. Methods: The clinical data, laboratory exam results, and follow-up outcomes of 182 patients with T3N0M0 renal cell carcinoma who underwent nephrectomy from 2007 to 2012 in Peking University First Hospital were retrospectively collected. The 5-year cancer-specific survival and 5-year recurrence-free survival of all the patients were calculated using Kaplan-Meier method, and the statistical significance between the survival curves were compared using the Logrank test. Variables with significant differences in the univariate analysis were subjected to the multivariate analysis by Cox regression model. All the comparisons were conducted using two-tailed test and P<0.05 was considered statistically significant. Results: A total of 182 patients were included in this study. Of all the 182 patients, 126 were male (69.23%) and 56 were female (30.77%). The mean age was (56.75±12.45) years. The median follow-up time was 48 months (3-99 months). At the end of the follow-up, 50 patients (27.47%) died due to the disease after a median of 29.74 months and 59 patients (32.42%) had tumor recurrence after a median of 22.12 months. The 5-year cancer-specific survival of all patients was 68.30% (95% CI: 60.16%-75.84%); the 5-year recurrencefree survival was 60.70% (95% CI: 53.16%-68.84%). In the univariate analysis, diabetes mellitus, tumor invasion status, Fuhrman grade, serum album, serum cholestenone, anemia, and neutrophils percentage were associated with the cancer-specific survival and Fuhrman grade, serum album and anemia were associated with the recurrence-free survival. Variables with significant differences on univariate analysis were included in Cox multivariate regression analysis. Multivariate Logistic regression analysis showed that diabetes mellitus (HR=2.434, 95% CI: 1.243-4.769, P=0.010), hypoalbuminemia (HR=2.188, 95% CI: 1.074-1.074, P=0.031), and anemia (HR=3.320, 95% CI: 1.839-5.991, P<0.001) were independent risk factors significantly associated with cancerspecific survival; and higher Fuhrman grade (HR=2.552, 95% CI: 1.433-4.545, P=0.001), anemia (HR=2.535, 95% CI: 1.497-4.293, P=0.001) were independent factors significantly associated with recurrence-free survival. Conclusion: Diabetes mellitus, hypoalbuminemia, and anemia were independent risk factors significantly associated with cancer-specific survival of T3N0M0 renal cell carcinoma patients; higher Fuhrman grade and anemia were independent risk factors significantly associated with tumor recurrence of T3N0M0 renal cell carcinoma patients.

Key words: Kidney neoplasms, Carcinoma, renal cell, Treatment outcome, Nephrectomy

中图分类号: 

  • R737.11
[1] 李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报(医学版), 2022, 54(1): 177-181.
[2] 周传香,周正,张晔,刘晓筱,高岩. 28例口腔基底样鳞状细胞癌的临床病理分析[J]. 北京大学学报(医学版), 2022, 54(1): 62-67.
[3] 苏俊琪,宋扬,谢尚. 口腔鳞状细胞癌患者修复重建术后感染的病原学特征及感染风险预测模型的构建[J]. 北京大学学报(医学版), 2022, 54(1): 68-76.
[4] 穆东亮,薛铖,安彬,王东信. 硬膜外阻滞与结直肠癌患者术后远期生存状态的关系:一项倾向性评分匹配的回顾性研究[J]. 北京大学学报(医学版), 2021, 53(6): 1152-1158.
[5] 朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报(医学版), 2021, 53(5): 964-969.
[6] 田雨,程晓悦,贺慧颖,王国良,马潞林. 肾细胞癌合并尿路瘤栓的临床病理特征: 6例报道及文献回顾[J]. 北京大学学报(医学版), 2021, 53(5): 928-932.
[7] 庞泳,张沙,杨华,周柔丽. LAPTM4B-35蛋白作为肝癌血清学诊断新标志物的探讨[J]. 北京大学学报(医学版), 2021, 53(4): 710-715.
[8] 肖若陶,刘承,徐楚潇,何为,马潞林. 术前血小板参数与局部进展期肾细胞癌预后[J]. 北京大学学报(医学版), 2021, 53(4): 647-652.
[9] 白杲琛,宋毅,金杰,虞巍,何志嵩. 多西他赛联合卡铂治疗转移性去势抵抗性前列腺癌的临床疗效[J]. 北京大学学报(医学版), 2021, 53(4): 686-691.
[10] 于妍斐,何世明,吴宇财,熊盛炜,沈棋,李妍妍,杨风,何群,李学松. 延胡索酸水合酶缺陷型肾细胞癌的临床病理特征及预后[J]. 北京大学学报(医学版), 2021, 53(4): 640-646.
[11] 孙争辉,黄晓娟,董靖晗,刘茁,颜野,刘承,马潞林. 临床T1期肾细胞癌肾窦侵犯的危险因素[J]. 北京大学学报(医学版), 2021, 53(4): 659-664.
[12] 赵勋,颜野,黄晓娟,董靖晗,刘茁,张洪宪,刘承,马潞林. 癌栓粘连血管壁对非转移性肾细胞癌合并下腔静脉癌栓患者手术及预后的影响[J]. 北京大学学报(医学版), 2021, 53(4): 665-670.
[13] 韩松辰,黄子雄,刘慧鑫,徐涛. 单侧肾细胞癌根治性切除术后的肾功能代偿[J]. 北京大学学报(医学版), 2021, 53(4): 680-685.
[14] 洪鹏,田晓军,赵小钰,杨飞龙,刘茁,陆敏,赵磊,马潞林. 肾移植术后双侧乳头状肾癌1例[J]. 北京大学学报(医学版), 2021, 53(4): 811-813.
[15] 李新飞, 彭意吉, 余霄腾, 熊盛炜, 程嗣达, 丁光璞, 杨昆霖, 唐琦, 米悦, 吴静云, 张鹏, 谢家馨, 郝瀚, 王鹤, 邱建星, 杨建, 李学松, 周利群. 肾部分切除术前CT三维可视化评估标准的初步探究[J]. 北京大学学报(医学版), 2021, 53(3): 613-622.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报(医学版), 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[5] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[6] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[7] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[8] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[9] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[10] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .